Target intelligence / Profile preview

Symplekin scaffold protein (SYMPK)

Target
SYMPK
Molecular classification
Scaffold protein, HEAT repeat protein (contains canonical HEAT repeats), Nuclear protein (participates in nuclear processes)
01

Overview

Symplekin scaffold protein (SYMPK) is a ubiquitously expressed, evolutionarily conserved nuclear protein functioning as a scaffold for the assembly of polyadenylation machinery during pre-mRNA processing and histone mRNA 3'-end maturation. Structurally, symplekin harbors a HEAT repeat domain supporting protein-protein interactions, and contributes to both the regulation of gene expression and the maintenance of mitotic spindle integrity. While it impacts cellular responses to certain drugs such as paclitaxel via modulation of mitosis, symplekin is not a direct drug target and is chiefly classified as a scaffold/structural protein rather than as a receptor, enzyme, transporter, or transcription factor. It is also found at tight junction plaques in select cell types, supporting possible roles in cell-cell adhesion and signaling.

Other names
SymplekinSYMPKSPKSYMPta1
02

Mechanism of action

None established for drugs, as symplekin is not a known pharmacological target. Paclitaxel sensitivity is indirectly modulated through symplekin’s role in mitosis.

03

Biological functions

Regulation of polyadenylation in pre-mRNA processingRecruitment of regulatory factors to the polyadenylation complex3'-end maturation of histone mRNAs (non-polyadenylated)Enhances SSU72 phosphatase activityComponent of tight junction plaque in some cell typesPromotes gene expressionSupports mitotic spindle integrity and fidelity, essential for proper cell division
04

Disease associations

Other — No clear evidence for a direct disease association or causative role

Beyond the preview

Go deeper on Symplekin scaffold protein (SYMPK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Symplekin scaffold protein (SYMPK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call